HALO Competitors & Alternatives
Compare Halozyme Therapeutics Inc with similar stocks in the same industry
Biotechnology
HALO
Main Stock$108.17
Tradestie Score
35
Market Cap
$8.77B
P/E Ratio
31.6
Revenue Growth
0.5%
Analyst Upside
-8.0%
Top Competitors
237 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
NBIX
Neurocrine Biosciences Inc
|
$152.57
|
$13.59B | 22.7 | 67 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$253.29
|
$12.36B | 19.7 | 51 | Compare |
|
EXEL
Exelixis Inc
|
$54.08
|
$11.09B | 16.9 | 52 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$36.30
|
$10.76B | - | 48 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$145.13
|
$10.74B | - | 40 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$66.70
|
$10.53B | 188.0 | 42 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$59.74
|
$10.49B | - | 40 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$81.50
|
$10.22B | - | 52 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$516.74
|
$10.01B | - | 51 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.32
|
$9.33B | 61.9 | 51 | Compare |
More HALO Analysis
Data updated: Aug 22, 2026 | Industry: Biotechnology (SIC 2836)
237 stocks in this industry